Continuous Wave Transscleral Cyclophotocoagulation and Micropulse Transscleral Cyclophotocoagulation: Efficacy and Effects on Corneal Endothelial Cell Count

Age: 21 - 90 years

Gender: All

Healthy Subjects: No

Recruitment Status: Recruiting

Contact Information:
646-943-7925 or 212-979-4671
Summary:

The purpose of this study is to investigate the surgical outcomes of the micropulse transscleral cyclophotocoagulation (mTSCPC) in patients with uncontrolled glaucoma; analyze intraocular pressure lowering effect; and correlate related treatment parameters pending endothelial cell counts.

Eligibility:



Inclusion Criteria:

- Patients with a minimum of 6 months follow-up with uncontrolled glaucoma as defined by:  Progression and/or intraocular pressure above target despite maximal tolerated medical therapy  Evidence of glaucomatous optic nerve damage and glaucomatous visual field loss in at least one hemifield

Find a Clinical Trial Find Cancer Clinical Trials